摘要
抗癌药物Vm-26是一种拓朴异构酶(TopoisomeraseⅡ,TopoⅡ)及组蛋白Hl激酶的抑制剂。本文就其对Hela细胞染色体形成的影响进行了观察。不同浓度的Vm-26加入Hela细胞培养液后48小时,进行染色体制备,光镜观察。当Vm-26的培养浓度在0.5-1.0μg/ml时,染色体的形成被阻断于分裂前期。当药物培养浓度于0.25μg/ml时,可见有相当数量的细胞处于分裂前期,其胞核内具有不规则的染色质凝缩。另外,尚可见极少的分裂中期染色体集簇形成,但大都伴有染色体的结构异常。结果提示:Vm-26可以通过抑制Hela细胞染色体的形成,而影响细胞正常的分裂、繁殖。
The antineoplastic agent,teniposide(Vm-26)is a inhibitor of the topoisomeraseⅡ(TopoⅡ).It can block the histone Hl phoshorylation. Its effects on the formation of Helacell chromosome was studied. The cell were cultured in diHerent concentration of Vm-26for 48 hours.Through preparation and observation of the chromosome with the conventionalrnethod,we noted that the chromosomal formation was blocked at G2 phase when the Vm- 26 was in a cuItured concentration of 0.5-1.0μg/ml.Mitotic cells were found to be pres- ence in 0.25μg/ml Vm- 26,but most of them failed to condense into the normal metaphasespreads,which always showed an irregular chromatin substance in the nuclei,or structure al- tered chromosomes.The results indicated that Vm- 26 can blocked Hela cell division by in-hibiting its chromosome formation,mainly acting on the late step of chromosome condensa- tion,while the chromatin fibers condense to form mitotic chromosome.
出处
《癌变.畸变.突变》
CAS
CSCD
1996年第3期161-164,共4页
Carcinogenesis,Teratogenesis & Mutagenesis
关键词
抗癌药
威猛
染色体形成
染色体凝缩
细胞分裂
chromosome formation
chromosome condensation
Vm- 26
abnormal chromo-somes
cell division